Erratum: Post-Transplant Malignancy in Liver Transplantation: A Single Center Experience(Medicine 93:28 (e310) DOI: 10.1097/MD.0000000000000310);Post-transplant malignancy in liver transplantation: A single center experience

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e310-

  Hsiao, Chih Yang ^a   Lee, Po Huang ^a,b   Ho, Cheng Maw ^a,b   Wu, Yao Ming ^a   Ho, Ming Chih ^a   Hu, Rey Heng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HEMANGIOENDOTHELIOMA; HUMAN; INFANT; KAPOSI SARCOMA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG CANCER; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PANCREAS CANCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; POSTTRANSPLANT MALIGNANCY; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; TAIWANESE; THYROID CANCER; THYROID PAPILLARY CARCINOMA; TRANSITIONAL CELL CARCINOMA; INCIDENCE; KAPLAN MEIER METHOD; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TAIWAN; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TAIWAN; YOUNG ADULT;

EID: 84920140572     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.md.0000464200.40426.f5     Document Type: Erratum

References (30)

1. Watt KDS, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010; 10: 1420-1427.
2. Na R, Grulich AE, Meagher NS, et al. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant. 2013; 13: 174-183.
3. Krynitz B, Edgren G, Lindelö f B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer. 2013; 132: 1429-1438.
4. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001; 34: 84-91.
5. Aberg F, Pukkala E, Höckerstedt K, et al. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 2008; 14: 1428-1436.
6. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370: 59-67.
7. Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. 2010; 30: 1247-1258.
8. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl. 2012; 18: 1277-1289.
9. Finkenstedt A, Graziadei IW, Oberaigner W, et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant. 2009; 9: 2355-2361.
10. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009; 125: 1747-1754.
11. Hsiao FY, Hsu WW. Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. Int Urol Nephrol. 2014; 46: 833-838.
12. Bureau of Health Promotion Department of Health, the Executive Yuan Taiwan. Cancer Registry Annual Report, 2010 Taiwan. February 2013. Available at: http://www.hpa.gov.tw/Bhpnet/Web/Stat/StatisticsShow.aspx-No=200911300001, accessed July 19, 2014.
13. Engels EA, Pfeiffer RM, Fraumeni JF Jr et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011; 306: 1891-1901.
14. Adami J, Gäbel H, Lindelö f B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003; 89: 1221-1227.
15. Athar M, Walsh SB, Kopelovich L, Elmets CA. Pathogenesis of nonmelanoma skin cancers in organ transplant recipients. Arch Biochem Biophys. 2011; 508: 159-163.
16. Saigal S, Norris S, Muiesan P, et al. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl. 2002; 8: 482-487.
17. Sampaio MS, Cho YW, Qazi Y, et al. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation. 2012; 94: 990-998.
18. Ajithkumar TV, Parkinson CA, Butler A, Hatcher HM. Management of solid tumours in organ-transplant recipients. Lancet Oncol. 2007; 8: 921-932.
19. Krikorian JG, Anderson JL, Bieber CP, et al. Malignant neoplasms following cardiac transplantation. JAMA. 1978; 240: 639-643.
20. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant. 1993; 12: S328-S336.
21. Ishikawa N, Tanabe K, Tokumoto T, et al. Clinical study of malignancies after renal transplantation and impact of routine screening for early detection: a single-center experience. Transplant Proc. 2000; 32: 1907-1910.
22. Hung YM, Chou KJ, Hung SY, et al. De novo malignancies after kidney transplantation. Urology. 2007; 69: 1041-1044.
23. Chiang YJ, Chen CH, Wu CT, et al. De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan. Transplant Proc. 2004; 36: 2150-2151.
24. Hsu RB, Chang CI, Tsai MK, et al. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients. Eur J Cardiothorac Surg. 2010; 37: 1117-1121.
25. Jain A, Nalesnik M, Reyes J, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002; 236: 429-436.
26. Lo RC, Chan SC, Chan KL, et al. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study. J Clin Pathol. 2013; 66: 392-398.
27. Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant. 2005; 5: 2222-2228.
28. Yokoyama I, Carr B, Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer. 1991; 68: 2095-2100.
29. Chatrath H, Berman K, Vuppalanchi R, et al. De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant. 2013; 27: 582-590.
30. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev. 2006; 28: 126-135.